2. Infection

Infection

Infection

Related Products

PDF 70.44 MB

Infection is a pathophysiological process that involves the invasion and colonization of a living organism (host) by disease-causing infectious agents, the reaction of host tissues to these agents and the toxins they produce, and the transmission of infectious agents to other hosts. Common infectious agents include viruses, viroids, prions, bacteria, nematodes, arthropods, and other macroparasites such as tapeworms. Hosts can fight infections using their immune system. Mammals often engage both innate and adaptive immune systems to eliminate infectious agents or inhibit their growth and transmission. When infection occurs, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic), antiviral, antifungal and antiparasitic agents.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-N5175
    Cephaibol A 304911-38-4 98%
    Cephaibol A has anti-Gram-positive bacterial activity, but no anti-Gram-negative bacterial activity. Cephaibol A also has the effect of deworming and anti-ectoparasite.
    Cephaibol A
  • HY-N5176
    Cephaibol B 304911-39-5 98%
    Cephaibol B has anti-Gram-positive bacterial activity, but no anti-Gram-negative bacterial activity. Cephaibol B also has the effect of deworming and anti-ectoparasite.
    Cephaibol B
  • HY-N5177
    Cephaibol D 280774-64-3 98%
    Cephaibol D is found in the strain of Acremonium tubaKii DSM 12774. Cephaibol D has weak antibacterial activity.
    Cephaibol D
  • HY-N5178
    Chloropeptin I 160219-64-7 98%
    Chloropeptin I inhibits the binding of gp120 to CD4 with IC50 of 2.0 μM, with the activity of selective anti-human immunodeficiency virus (HIV).
    Chloropeptin I
  • HY-N5181
    Parvodicin C3 110882-86-5 98%
    Parvodicin C3 is a glycopeptide antibiotic. Parvodicin C3 has inhibitory effect on Staphylococcus aureus, Staphylococcus furfur, Staphylococcus hemolyticus and Enterococcus faecalis.
    Parvodicin C3
  • HY-N5184
    Nocathiacin Ⅲ 256230-47-4 98%
    Nocathiacin III (Nocathiacine III) is highly resistant to Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), penicillin-resistant Streptococcus pneumoniae (PRSP) and multidrug resistant Enterococcus faecalis (MREF).
    Nocathiacin Ⅲ
  • HY-N5185
    Cyclothiazomycin 133352-26-8 98%
    Cyclothiazomycin selectively inhibits renin activity and does not inhibit pepsin, aspartic acid, serine, mercaptan protease and metalloproteinases. Cyclothiazomycin has weak antifungal activity.
    Cyclothiazomycin
  • HY-N5186
    Cypemycin 154277-21-1 98%
    Cypemycin is a linaridin antibiotic that can inhibit cancer cell activity, inhibits P388 leukemia cells with IC50 of 1.3 μg/mL. Cypemycin can inhibit human tumor cells such as HeLa S3, HHCC-1, HCCS-M and Slex with IC50 of >25 μg/mL.
    Cypemycin
  • HY-N5188
    Emerimicin III 52931-42-7 98%
    Emerimicin III mainly has activity against Gram-positive bacteria.
    Emerimicin III
  • HY-N5189
    Emerimicin IV 52931-43-8 98%
    Emerimicin IV mainly has activity against Gram-positive bacteria.
    Emerimicin IV
  • HY-N5190
    Enamidonin 2271109-33-0 98%
    Enamidonin is a lipopeptide antibiotic. Enamidonin inhibits EGF-dependent [3H] thymidine involvement in Balb/MK cells (IC50 is 10 μg/mL), and it can restore the deformed SRCTS-NRK form to the normal flat form (ED50 is 10 μg/mL). No antimicrobial activity.
    Enamidonin
  • HY-N5192
    Galacardin A 137801-55-9 98%
    Galacardin A has anti-Gram-positive bacterial activity.
    Galacardin A
  • HY-N5193
    Galacardin B 137801-54-8 98%
    Galacardin B has anti-Gram-positive bacterial activity.
    Galacardin B
  • HY-N5194
    Lipohexin 193751-58-5 98%
    Lipohexin is a peptide antibiotic. Lipohexin has anti-Gram-positive bacterial effect. Lipohexin had competitive inhibitory effect on human placental proline endopeptidase with an IC50 of 3.5 μM. Lipohexin inhibits the proline endopeptidase from the Flavobacterium meningoseptiu with an IC50 of 25 μM.
    Lipohexin
  • HY-N5195
    Nocathiacin II 256230-46-3 98%
    Nocathiacin II (Nocathiacine II) is highly resistant to Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), penicillin-resistant Streptococcus pneumoniae (PRSP) and multidrug resistant Enterococcus faecalis (MREF).
    Nocathiacin II
  • HY-N5196
    Nocathiacin I 214044-52-7 98%
    Nocathiacin I (Nocathiacine I) is highly resistant to Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), penicillin-resistant Streptococcus pneumoniae (PRSP) and multidrug resistant Enterococcus faecalis (MREF).
    Nocathiacin I
  • HY-N5197
    Dapdiamide A 1196054-26-8 98%
    Dapdiamide A is an antibiotic found in Pantoea agglomerans CU0119 strain, exhibiting antibacterial activity and potential applications in anti-infective research.
    Dapdiamide A
  • HY-N5199
    4"-Demethylgentamicin C2 66277-10-9 98%
    4"-Demethylgentamicin C2 has anti-Gram-positive and negative bacteria activity.
    4
  • HY-N5200
    4"-Demethylgentamicin C1a 61769-70-8 98%
    4"-Demethylgentamicin C1a has anti-Gram-positive and negative bacteria activity.
    4
  • HY-N5201
    4"-Demethylgentamicin C1 66322-28-9 98%
    4"-Demethylgentamicin C1 has anti-Gram-positive and negative bacteria activity.
    4
Cat. No. Product Name / Synonyms Application Reactivity